Therapeutic Trial Design Issues for Future Disease-Modifying Therapy of Multiple System Atrophy

Clinical Neurology - Japan
doi 10.5692/clinicalneurol.51.910
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Societas Neurologica Japonica

Related search

Clinical Trial Methodologies for Disease-Modifying Therapeutic Approaches

Neurobiology of Aging
AgingGerontologyDevelopmental BiologyGeriatricsNeuroscienceNeurology
2011English

Multiple Sclerosis Disease-Modifying Therapy and Pregnancy

Multiple Sclerosis
Neurology
2016English

The Neuropathology of Multiple System Atrophy and Its Therapeutic Implications

Autonomic Neuroscience: Basic and Clinical
EndocrineMolecular NeuroscienceNeurologyCellularAutonomic Systems
2018English

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics

Archives of Neurology
1999English

Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy

Acta Neurologica Scandinavica
MedicineNeurology
2017English

Imaging Markers of Disease Progression in Multiple System Atrophy

Future Neurology
Neurology
2019English

Attentional Functions in Multiple System Atrophy and Parkinson's Disease.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1996English

Stridor in Multiple System Atrophy

Neurology
Neurology
2019English

Multiple System Atrophy, Cerebellar Type

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy